This review presented fundamental information regarding two categories of GLP-1 receptor agonists (GLP-1RAs): peptide-based and small molecule compounds, and elaborated their potential neuroprotective effects by inhibiting neuroinflammation, reducing neuronal apoptosis, and ultimately improving cognitive function in various neurodegenerative diseases
It is estimated that approximately 936 million adults worldwide suffer from moderate-to-severe OSAS, the vast majority of whom remain undiagnosed (3)
In the long term, dietary induced weight loss is accompanied by reduced concentrations of total PYY and CCK and increased concentrations of acylated ghrelin and these changes have been shown to precede weight regain in people with obesity [11]
People taking GLP-1 drugs are more likely to see their doctors regularly and/or receive thyroid cancer screening, and this higher level of surveillance can then result in more diagnosed cancers, rather than any effect of the drug
Allow it to dry completely before proceeding